InvestorsHub Logo
Followers 41
Posts 5379
Boards Moderated 0
Alias Born 11/15/2013

Re: SitTight post# 398166

Thursday, 06/08/2023 3:03:31 PM

Thursday, June 08, 2023 3:03:31 PM

Post# of 402948
I share your thoughts. Leo reported in vitro and in vivo studies seeing positive results (there's that "p" word). Also it was reported that further testing was planned by NIH/NIAID-affiliated and other academic researchers. I also believe we have a good shot at a deal. Good luck to us all. Btw you own a substantial lot. Go BeaMed!
WAKEFIELD, MA / March 15, 2023 Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today that based on positive findings new testing of Brilacidin in additional in vitro and in vivo models against hard-to-treat fungal pathogens is planned by NIH/NIAID-affiliated and other academic researchers. Brilacidin is the Company’s defensin mimetic drug candidate exhibiting antimicrobial and immunomodulatory properties.

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News